Jun 24, 2024
Across Health has been a part of Precision Value & Health since 2021, and this wider rebrand signals fuller integration of services across all Precision teams to better facilitate access to life-changing medicine.
A new International matrix structure brings together the teams based outside the US (including International Europe-based companies Across Health and Makara Health) to work together more closely to meet the needs of International clients.
GHENT, Belgium, 24 June 2024 – Across Health today announced that the company has rebranded as Precision AQ. The new name is the culmination of years of strategic development and integration within Precision Value & Health (of which Across Health has been a part since 2021). Precision AQ now forms a single company with the unrivalled scale, services, and strengths to help life sciences companies navigate the complexities surrounding patient access to life-changing therapies across the product lifecycle.
Combined services under the new brand include: omnichannel solutions, investor relations & external communications, global pricing and market access strategy, evidence generation, brand promotion, medical education, learning and development, PR, and patient insights & support.
In addition to the Belgium-based omnichannel strategy and product specialists, Across Health, which was acquired by Precision three years ago, the rebrand also includes a recent UK-based International acquisition, Makara Health Communications.
Unifying nine organisations under one name and brand signals a shift to a more streamlined and comprehensive experience for Precision AQ clients making it easier to access the company’s considerable global expertise and services.
“We’re confident that this coming together will provide our clients with easier access to cross-functional teams and experts, enabling us to offer broader services and bigger programmes,” said Ruud Kooi, MD Across Health. “And further enhance our ability to support our clients' evolving projects with even greater efficiency and innovation."
Precision AQ President, Doug Fulling commented: “Precision AQ exists for one reason: To empower access to life-changing medicine for all. We are stronger together, combining the strength of life-science experts, advisors, and creators, all working towards the same goal: changing the blueprint for access.”
The name itself, which stands for Precision Access Quotient, reflects the organisation’s approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in a medicine’s journey from bench to bedside that the organisation feels is often overlooked.
International offering
Alongside the rebrand, Precision AQ recently appointed Louise Sharp as EVP, General Manager of its International team, with a view to facilitating greater collaboration across the services lines that sit outside the US, and signalling to International clients the considerable expertise and experience within this region.
Sharing her excitement about her new role, Sharp said: “Moving hearts and minds is our business, and we believe this takes equal parts science and humanity. My role will focus on using our patient-first mission to ensure the organisation’s blueprint for access is tailored to the specific needs of our International audiences. I am thrilled to be taking on this newly created role and look forward to continuing to augment and grow Precision AQ’s International footprint.”
Added Kooi: “We are excited about the opportunities that lie ahead with Precision AQ International, and very much look forward to continuing our partnerships with valued clients under this new banner.”
Data-Driven Precision, Unified Access
According to Doug Fulling, the company has built an unrivalled organisation by bringing together the best experts in the business to provide the most comprehensive view of the healthcare journey, overcoming challenges with data-driven precision, while always grounding solutions in empathy.
Precision AQ partners have unfettered access to data, experience and knowledge from any point in the therapy journey to help guide decisions based on real-world experience of what’s to come. Precision AQ’s offerings range from economics outcomes research in the U.S., to key opinion leader (KOL) and digital opinion leader (DOL) mapping and omnichannel customer insights across the world. Combined, these capabilities can break down knowledge and process silos that create unforeseen roadblocks in bringing therapies to market.
“Our teams range from deeply analytical to highly creative, giving partners comprehensive access to over 100 types of specialists that, combined, provide a unique and comprehensive perspective across the entire commercialisation continuum,” said Fulling. “No matter how few or how many of our diverse specialist teams you engage with, you get the added value of our collective expertise across all disciplines to help guide you through what’s to come.”
About Precision AQ
Precision AQ, formerly known as Precision Value & Health, helps life sciences companies navigate the complexities of access, across a product’s lifecycle, to get more therapies to the patients that need them. The company comprises life-science experts, advisors, and creators working to change the blueprint for access with data-driven precision, grounded in empathy. In addition to Across Health (Omnichannel insights and strategy), the new Precision AQ unifies several organizations under one name and brand, including PRECISIONadvisors (global pricing and market access strategy), PRECISIONeffect (healthcare communications and marketing), PRECISIONheor (evidence generation and strategy), PRECISIONscientia (medical communications), PRECISIONvalue (managed markets marketing), PRECISIONxtract (data-driven analytics and insights), Stern Investor Relations (investor relations and external communications), and Makara Health (International brand, medical education, L&D, PR and patient insights services).
Visit: www.precisionAQ.com